文献速递角膜与眼表疾病眼整形与眼眶

类风湿关节炎患者外周溃疡性角膜病变所致角膜穿孔:英国眼科监测单位的流行病学发现

Corneal perforation from peripheral ulcerative keratopathy in patients with rheumatoid arthritis: epidemiological findings of the British Ophthalmological Surveillance Unit.
PubMed 文献 · Br J Ophthalmol · 2017-12-15

本研究通过英国眼科监测单位前瞻性收集2012年7月至2014年6月类风湿关节炎(RA)患者因外周溃疡性角膜病变(PUK)发生角膜穿孔的新病例,共识别28例患者30只眼,估算英国发病率为0.234/百万/年。1年全因死亡率为6/25(24%),双眼穿孔者升至1/2(50%);存活者中13/20(65%)视力预后差(≤数指)。结论强调尽管治疗,此类角膜穿孔仍伴随严重眼部病变和高死亡率。

要点

  • RA相关PUK角膜穿孔的英国估算发病率为0.234/百万/年。
  • 1年全因死亡率为6/25(24%),双眼穿孔者为1/2(50%)。
  • 存活患者中13/20(65%)视力≤数指,5/19(26%)符合视力损害登记标准。

核心结论

  • 本研究强调尽管给予治疗,RA患者因PUK发生角膜穿孔仍伴随严重的眼部病变和高死亡率。
  • 双眼穿孔时死亡率翻倍,这应作为即将发生的严重医疗问题的预兆。

研究设计与样本

  • 通过英国眼科监测单位于2012年7月至2014年6月前瞻性收集英国RA患者因PUK发生角膜穿孔的新病例。
  • 初始问卷收集就诊时及最初2周管理数据,随访问卷收集1年眼部病变和死亡率数据。

主要发现

  • 2年内识别28例患者30只眼,估算英国发病率为0.234/百万/年。
  • 20/27(74%)为女性,中位年龄68岁(范围41-84)。
  • 最常见的初始管理为氰基丙烯酸酯胶联合绷带接触镜、口服类固醇、局部和口服抗生素及润滑剂。
  • 1年时存活者的长期管理包括12/20(60%)眼行角膜移植。
  • 1年全因死亡率为6/25(24%),双眼穿孔者为1/2(50%);存活者中13/20(65%)视力预后差(≤数指),8/25(40%)有双侧PUK,2/25(8%)有双侧穿孔,5/19(26%)符合视力损害登记标准。

关键数值与推荐

  • 英国RA相关PUK角膜穿孔估算发病率为0.234/百万/年。
  • 1年全因死亡率为6/25(24%),双眼穿孔者为1/2(50%)。
  • 存活者中13/20(65%)视力≤数指,5/19(26%)符合视力损害登记标准。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND/AIMS: This study quantifies the threat to vision and the survival in patients presenting with peripheral ulcerative keratopathy (PUK) corneal perforation associated with rheumatoid arthritis (RA) in the UK. METHODS: New cases of corneal perforation from PUK in patients with RA were prospectively collected from the UK via the British Ophthalmological Surveillance Unit from July 2012 to June 2014. An initial questionnaire collected data on presentation and the first 2 weeks' management, and a follow-up questionnaire collected 1-year data on ocular morbidity and mortality. RESULTS: 30 eyes of 28 patients were identified over 2 years, estimating a UK incidence of 0.234/million/year. 20/27 (74%) were female, with a median age of 68 years (range 41-84). The most common initial management was cyanoacrylate glue with a bandage contact lens, oral steroids, topical and oral antibiotics, and lubricants. Long-term management included corneal grafting in 12/20 (60%) eyes of patients living at 1 year. The 1-year all-cause mortality was 6/25 (24%), which increased to 1/2 (50%) if both eyes had perforated. In the remaining patients alive at 1-year follow-up, there was a 13/20 (65%) poor visual outcome of less than or equal to counting fingers. 8/25 (40%) patients had bilateral PUK, with 2/25 (8%) having bilateral perforation. 5/19 (26%) patients alive at 1-year follow-up were eligible for sight impairment registration. CONCLUSION: This study highlights the serious ocular morbidity and high mortality associated with corneal perforation from PUK in patients with RA despite treatment. The mortality doubled if both eyes perforated, which should serve as a harbinger of impending serious medical problems.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Timlin HM, Hall HN, Foot B, et al. Corneal perforation from peripheral ulcerative keratopathy in patients with rheumatoid arthritis: epidemiological findings of the British Ophthalmological Surveillance Unit. Br J Ophthalmol. 2017. PMID: 29246891. doi:10.1136/bjophthalmol-2017-310671

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。